arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2501.03581eess.AScs.SD
收藏

面向帕金森病诊断的可泛化语音标志物研究

Towards a Generalizable Speech Marker for Parkinson's Disease Diagnosis

Institute for Creative Technologies, University of Southern California(南加州大学创意技术研究所);University of Southern California(南加州大学);School of Medicine, University of California Irvine(加州大学欧文分校医学院)

Maksim Siniukov, Ellie Xing, Sanaz Attaripour Isfahani, Mohammad Soleymani

AI总结:

本研究针对帕金森病早期诊断窗口期易遗漏的问题,提出结合域适应与自监督学习的语音识别方法,基于HuBERT模型在多语言公开数据集上实现了高特异性与灵敏度的泛化诊断,提供了非侵入式的低成本诊断方案。

摘要:

帕金森病(Parkinson's Disease, PD)是一种以运动症状为特征的神经退行性疾病,早期阶段包括发声功能改变。早期诊断不仅对提升PD患者的生活质量至关重要,还能在神经退行性病变早期提高潜在疾病修饰疗法的疗效,而这一窗口期常被现有诊断工具错过。本文提出一种基于域适应和自监督学习的更具泛化性的PD识别方法。我们验证了该方法在不同语言的多样数据集上的泛化能力。该方法利用HuBERT(一种最初为语音识别训练的大型深度神经网络),以自监督方式在与目标人群(即老年人)相似的群体的未标注语音数据上进一步训练。随后对模型进行微调与域适应,使其可跨英语、意大利语、西班牙语等多种语言的不同数据集使用。在四个公开PD数据集上的评估验证了模型的有效性,平均特异性达92.1%,平均灵敏度达91.2%。该方法可在大规模人群中提供客观一致的评估,解决了人工评估固有的差异性问题,提供了一种非侵入性、低成本且易获取的诊断选择。

英文摘要:

Parkinson's Disease (PD) is a neurodegenerative disorder characterized by motor symptoms, including altered voice production in the early stages. Early diagnosis is crucial not only to improve PD patients' quality of life but also to enhance the efficacy of potential disease-modifying therapies during early neurodegeneration, a window often missed by current diagnostic tools. In this paper, we propose a more generalizable approach to PD recognition through domain adaptation and self-supervised learning. We demonstrate the generalization capabilities of the proposed approach across diverse datasets in different languages. Our approach leverages HuBERT, a large deep neural network originally trained for speech recognition and further trains it on unlabeled speech data from a population that is similar to the target group, i.e., the elderly, in a self-supervised manner. The model is then fine-tuned and adapted for use across different datasets in multiple languages, including English, Italian, and Spanish. Evaluations on four publicly available PD datasets demonstrate the model's efficacy, achieving an average specificity of 92.1% and an average sensitivity of 91.2%. This method offers objective and consistent evaluations across large populations, addressing the variability inherent in human assessments and providing a non-invasive, cost-effective and accessible diagnostic option.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑